echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Plos Med: Breast cancer patients are at higher risk of anxiety and depression!

    Plos Med: Breast cancer patients are at higher risk of anxiety and depression!

    • Last Update: 2021-03-19
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    According to data released by the International Agency for Research on Cancer ( IARC ) in December 2020 , breast cancer has surpassed lung cancer as the most common cancer in the world.


    According to data released by the International Agency for Research on Cancer ( IARC ) in December 2020 , breast cancer has surpassed lung cancer as the most common cancer in the world.


    Recently, a study published in the journal Plos Med showed that compared with women without cancer, breast cancer survivors have a higher risk of anxiety, depression, sleep, sexual dysfunction, fatigue, and pain.


    Recently, a study published in the journal Plos Med showed that compared with women without cancer, breast cancer survivors have a higher risk of anxiety, depression, sleep, sexual dysfunction, fatigue, and pain.


    In this study, a matched cohort study was conducted using data routinely collected in primary care across the UK to quantify the association between breast cancer history and depression, anxiety, and other mental health-related outcomes.


    In this study, a matched cohort study was conducted using data routinely collected in primary care across the UK to quantify the association between breast cancer history and depression, anxiety, and other mental health-related outcomes.


    The results found that breast cancer survival rate and anxiety (adjusted hazard ratio ( breast cancer survival rate and anxiety (adjusted hazard ratio ( breast cancer survival rate and anxiety (adjusted hazard ratio ( HR )) = 1.


    It is worth noting that the HR for anxiety and depression decreases over time, but the risk of anxiety and depression increases 2 to 4 years after cancer diagnosis .


    It is worth noting that the HR of anxiety and depression of anxiety and depression decreases over time, but the risk of anxiety and depression increases 2 to 4 years after cancer diagnosis .


    In summary, breast cancer patients are related to a variety of poor mental health.


    Original source

    Helena Carreira, Rachael Williams, Garth Funston, Susannah Stanway, Krishnan Bhaskaran.


    Helena Carreira ,Rachael Williams, Garth Funston, Susannah Stanway, Krishnan Bhaskaran.
    plos.
    org/plosmedicine/article?id=10.
    1371/journal.
    pmed.
    1003504" target="_blank" rel="noopener">Associations between breast cancer survivorship and adverse mental health outcomes: A matched population-based cohort study in the United Kingdom .
    Plos Med.
    2021.
    org/10.
    1371/journal.
    pmed.
    1003504">https://doi.
    org /10.
    1371/journal.
    pmed.
    1003504plos.
    org/plosmedicine/article?id=10.
    1371/journal.
    pmed.
    1003504" target="_blank" rel="noopener"> Associations between breast cancer survivorship and adverse mental health outcomes: A matched population-based cohort study in the United Kingdom org/10.
    1371/journal.
    pmed.
    1003504">https://doi.
    org/10.
    1371/journal.
    pmed.
    1003504 https://doi .
    org/10.
    1371/journal.
    pmed.
    1003504 leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.